Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.705 USD | -6.72% | -5.28% | -69.40% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-69.40% | 303M | |
+0.82% | 93.19B | |
-1.32% | 39.62B | |
-12.64% | 33.78B | |
+64.77% | 26.82B | |
-15.83% | 15.35B | |
-5.96% | 13.13B | |
-11.38% | 11.6B | |
-49.84% | 10.26B | |
+5.24% | 9.43B |
- Stock Market
- Equities
- RVNC Stock
- News Revance Therapeutics, Inc.
- Piper Sandler Adjusts Price Target on Revance Therapeutics to $44 From $50, Maintains Overweight Rating